CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Akso Health Group - AHG CFD

    0.949
    4.91%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.152
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.998
    Open* 0.995
    1-Year Change* 11.92%
    Day's Range* 0.899 - 1.019
    52 wk Range 0.20-1.17
    Average Volume (10 days) 677.47K
    Average Volume (3 months) 3.19M
    Market Cap 25.02M
    P/E Ratio -100.00K
    Shares Outstanding 68.60M
    Revenue 13.18M
    EPS -0.58
    Dividend (Yield %) N/A
    Beta 0.54
    Next Earnings Date Dec 4, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 22, 2023 0.949 -0.012 -1.25% 0.961 1.019 0.899
    Sep 21, 2023 0.998 0.042 4.39% 0.956 1.019 0.909
    Sep 20, 2023 0.959 -0.026 -2.64% 0.985 1.019 0.921
    Sep 19, 2023 1.029 0.020 1.98% 1.009 1.109 0.979
    Sep 18, 2023 1.019 -0.110 -9.74% 1.129 1.149 0.998
    Sep 15, 2023 1.059 0.074 7.51% 0.985 1.169 0.949
    Sep 14, 2023 0.939 0.009 0.97% 0.930 1.009 0.889
    Sep 13, 2023 0.998 0.092 10.15% 0.906 1.049 0.895
    Sep 12, 2023 0.998 0.039 4.07% 0.959 1.009 0.889
    Sep 11, 2023 0.998 0.123 14.06% 0.875 1.009 0.869
    Sep 8, 2023 1.008 0.011 1.10% 0.997 1.048 0.953
    Sep 7, 2023 0.958 -0.039 -3.91% 0.997 1.008 0.878
    Sep 6, 2023 0.978 -0.030 -2.98% 1.008 1.098 0.958
    Sep 5, 2023 1.038 0.214 25.97% 0.824 1.078 0.750
    Sep 1, 2023 0.758 -0.117 -13.37% 0.875 0.884 0.638
    Aug 31, 2023 0.888 0.094 11.84% 0.794 0.968 0.748
    Aug 30, 2023 0.788 0.043 5.77% 0.745 0.864 0.678
    Aug 29, 2023 0.678 0.050 7.96% 0.628 0.728 0.590
    Aug 28, 2023 0.498 0.045 9.93% 0.453 0.578 0.389
    Aug 25, 2023 0.446 0.123 38.08% 0.323 0.640 0.287

    Akso Health Group Events

    Time (UTC) Country Event
    Monday, December 4, 2023

    Time (UTC)

    00:30

    Country

    US

    Event

    Half Year 2024 Akso Health Group Earnings Release
    Half Year 2024 Akso Health Group Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2023 2022 2021 2020 2019
    Total revenue 13.1816 6 0 6.91447 3.69522
    Revenue 13.1816 6 0 6.91447 3.69522
    Total Operating Expense 27.4484 9.26046 4.24125 55.0202 10.8844
    Selling/General/Admin. Expenses, Total 15.5358 3.06146 2.08663 22.2991 10.8844
    Research & Development 1.03256 0
    Operating Income -14.2669 -3.26046 -4.24125 -48.1057 -7.18919
    Other, Net 1.20036 -0.74782 -0.05208 1.23216 0.38115
    Net Income Before Taxes -13.0665 -4.00828 -4.29333 -46.8735 -6.80804
    Net Income After Taxes -13.084 -4.1011 -4.29333 -47.3635 -7.61575
    Net Income Before Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
    Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
    Income Available to Common Excl. Extra. Items -13.1965 -4.10243 -4.29333 -47.3635 -7.61575
    Income Available to Common Incl. Extra. Items -1.35992 -16.8511 -34.827 -71.1984 5.53258
    Dilution Adjustment
    Diluted Net Income -1.35992 -16.8511 -34.827 -71.1984 5.53258
    Diluted Weighted Average Shares 68.5981 59.6121 48.838 48.7572 48.6932
    Diluted EPS Excluding Extraordinary Items -0.19237 -0.06882 -0.08791 -0.97142 -0.1564
    Diluted Normalized EPS -0.19237 -0.06882 -0.08791 -0.58227 -0.1564
    Minority Interest -0.1125 -0.00133
    Interest Expense (Income) - Net Operating 0 0.80414 2.15462 2.49871 0
    Unusual Expense (Income) 29.1898 0
    Total Extraordinary Items 11.8366 -12.7486 -30.5337 -23.8349 13.1483
    Cost of Revenue, Total 11.9126 5.39487 0
    Gross Profit 1.26899 0.60513 0
    Mar 2023 Sep 2022 Mar 2022 Sep 2021 Mar 2021
    Total revenue 1.30914 11.8724 5.75408 0.24592 0
    Revenue 1.30914 11.8724 5.75408 0.24592 0
    Total Operating Expense 14.5258 12.9226 0.54471 8.71575 4.24125
    Selling/General/Admin. Expenses, Total 13.3444 2.10033 0.22 2.84146 2.08663
    Research & Development 0.09108 -0.24023 0.24023
    Interest Expense (Income) - Net Operating 0 0 0.20414 0.6 2.15462
    Other Operating Expenses, Total -5.03406 5.03406
    Operating Income -13.2167 -1.05019 5.20937 -8.46983 -4.24125
    Other, Net -0.68801 1.88837 -0.31943 -0.42838 -0.05208
    Net Income Before Taxes -13.9047 0.83818 4.88993 -8.89821 -4.29333
    Net Income After Taxes -13.9105 0.82644 4.81502 -8.91611 -4.29333
    Net Income Before Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
    Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
    Income Available to Common Excl. Extra. Items -14.0069 0.81034 4.81369 -8.91611 -4.29333
    Income Available to Common Incl. Extra. Items -2.17026 0.81034 -7.93495 -8.91611 -34.827
    Diluted Net Income -2.17026 0.81034 -7.93495 -8.91611 -34.827
    Diluted Weighted Average Shares 68.5981 68.5981 68.549 50.6754 48.838
    Diluted EPS Excluding Extraordinary Items -0.20419 0.01181 0.07022 -0.17595 -0.08791
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -0.20419 0.01181 0.07022 -0.17595 -0.08791
    Unusual Expense (Income)
    Total Extraordinary Items 11.8366 -12.7486 0 -30.5337
    Cost of Revenue, Total 1.18137 10.7312 5.39487
    Gross Profit 0.12777 1.14122 0.35921
    Minority Interest -0.0964 -0.0161 -0.00133
    Total Adjustments to Net Income 0 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 50.6244 30.1225 52.0182 97.6806 163.123
    Cash and Short Term Investments 21.9253 15.1287 6.6681 57.3721 132.622
    Cash & Equivalents 21.9253 15.1287 6.6681 57.3721 132.622
    Total Receivables, Net 20.0152 14.401 36.2627 36.9735 29.2517
    Prepaid Expenses 0.88796 0.59278 0.40082 3.33497 1.24856
    Total Assets 50.6798 31.6855 80.4762 173.256 163.89
    Property/Plant/Equipment, Total - Net 0.05543 0.06689 0.76357 1.25372 0.76709
    Note Receivable - Long Term 0 1.49612 22.3081 39.8105
    Other Long Term Assets, Total 3.78633 3.72118 0
    Total Current Liabilities 38.3942 14.414 12.3618 26.5627 23.8468
    Accrued Expenses 1.06905 1.14251 1.89035 2.7911 3.78696
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 37.3251 3.27146 10.4714 23.7716 20.0598
    Total Liabilities 38.3962 14.414 32.3753 46.7527 23.8468
    Total Long Term Debt 0 0 20 20 0
    Total Equity 12.2836 17.2715 48.1009 126.503 140.043
    Common Stock 0.00698 0.005 0.005 0.00496 0.0048
    Additional Paid-In Capital 71.0219 60.6151 60.5596 59.8069 58.418
    Retained Earnings (Accumulated Deficit) -53.1077 -36.2566 -1.42962 69.7688 77.2411
    Other Equity, Total -1.64922 -3.10354 -7.0457 -1.75696 4.37923
    Total Liabilities & Shareholders’ Equity 50.6798 31.6855 80.4762 173.256 163.89
    Total Common Shares Outstanding 68.5981 48.8506 48.8183 49.2041 15.986
    Accounts Receivable - Trade, Net 0.01525 0.02836 0.00188 0.41864
    Property/Plant/Equipment, Total - Gross 0.14131 0.13197 0.80927 1.99927
    Accumulated Depreciation, Total -0.08588 -0.06508 -0.0457 -0.74555
    Long Term Investments 0 1.6 30.7898
    Long Term Debt 0 20 20
    Other Liabilities, Total 0 0.0135 0.18996
    Treasury Stock - Common -3.98837 -3.98837 -3.98837 -1.32047
    Other Current Assets, Total 0 8.68651
    Current Port. of LT Debt/Capital Leases 0 10 0
    Total Inventory 7.79582
    Minority Interest 0.00198
    Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
    Total Current Assets 20.871 50.6244 22.3104 30.1225 47.8994
    Cash and Short Term Investments 9.99056 21.9253 15.4568 15.1287 21.9013
    Cash & Equivalents 9.99056 21.9253 15.4568 15.1287 21.9013
    Total Receivables, Net 7.92858 20.0152 6.56152 14.3892 18.2805
    Accounts Receivable - Trade, Net 7.92858 0.01525 0.01776 0.02836 0.28878
    Prepaid Expenses 2.05229 0.88796 0.29201 0.60452 0.71759
    Total Assets 20.9073 50.6798 32.5244 31.6855 60.181
    Property/Plant/Equipment, Total - Net 0.03631 0.05543 0.06881 0.06689 0.07214
    Long Term Investments 0 1.6
    Note Receivable - Long Term 0 0 1.49612 10.6095
    Other Long Term Assets, Total 10.1453 0
    Total Current Liabilities 10.9772 38.3942 12.9722 14.414 13.1289
    Accrued Expenses 1.18238 1.06905 0.945 1.14251 1.35086
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 9.79486 37.3251 2.02725 3.27146 11.7781
    Total Liabilities 10.9944 38.3962 12.9722 14.414 33.1289
    Total Long Term Debt 0 0 0 0 20
    Long Term Debt 0 20
    Other Liabilities, Total 0 0
    Total Equity 9.91285 12.2836 19.5522 17.2715 27.052
    Common Stock 0.00698 0.00698 0.00698 0.005 0.005
    Additional Paid-In Capital 71.0219 71.0219 71.0219 60.6151 60.6151
    Retained Earnings (Accumulated Deficit) -52.2973 -53.1077 -45.1727 -36.2566 -25.0173
    Treasury Stock - Common -3.98837 -3.98837 -3.98837 -3.98837 -3.98837
    Other Equity, Total -4.83032 -1.64922 -2.31557 -3.10354 -4.56238
    Total Liabilities & Shareholders’ Equity 20.9073 50.6798 32.5244 31.6855 60.181
    Total Common Shares Outstanding 68.5981 68.5981 68.5981 48.8506 48.8572
    Other Current Assets, Total 0 7.00003
    Current Port. of LT Debt/Capital Leases 0 10 10
    Total Inventory 0.89956 7.79582
    Minority Interest 0.01721 0.00198
    Property/Plant/Equipment, Total - Gross 0.12593
    Accumulated Depreciation, Total -0.08962
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -16.8497 -31.5522 -47.3635 5.53258 65.5106
    Cash From Operating Activities -8.62837 10.0585 -58.2787 -1.73108 87.723
    Cash From Operating Activities 0.01839 0.01516 0.12052 0.4068 0.17438
    Deferred Taxes 0 0 3.3083 -3.72408 0.41562
    Changes in Working Capital -2.56415 23.2255 -32.9 -11.6206 19.7935
    Cash From Investing Activities -19.9639 -0.00066 12.7754 -68.1066 -27.6238
    Capital Expenditures -0.00486 0 -0.20036 -0.94481 -0.45603
    Cash From Financing Activities 34.7811 -9.03722 -1.55219 -0.02938 47.5163
    Financing Cash Flow Items 10.0172 0.03694 7.36367 -0.318 4.24256
    Issuance (Retirement) of Stock, Net 0 0.00001 -2.26261 -0.16385 43.2737
    Foreign Exchange Effects 0.60772 3.18293 0.60864 -5.38333 5.77472
    Net Change in Cash 6.7966 4.20351 -46.4469 -75.2503 113.39
    Non-Cash Items 10.7671 18.3701 18.556 7.67422 1.82887
    Cash Taxes Paid 0.03862 0.00976 3.20938 12.2482 1.01696
    Other Investing Cash Flow Items, Total -19.959 -0.00066 12.9757 -67.1617 -27.1678
    Total Cash Dividends Paid 0 0 -19.5475
    Issuance (Retirement) of Debt, Net 24.7639 -9.07416 -6.65324 20
    Sep 2022 Mar 2022 Sep 2021 Mar 2021 Sep 2020
    Net income/Starting Line 0.82644
    Cash From Operating Activities -1.33412
    Cash From Operating Activities 0.01384
    Non-Cash Items 0
    Changes in Working Capital -2.17439
    Cash From Investing Activities 20
    Other Investing Cash Flow Items, Total 20
    Cash From Financing Activities -27.5138
    Financing Cash Flow Items -27.5138
    Foreign Exchange Effects -3.0868
    Net Change in Cash -11.9348
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Renaissance Technologies LLC Hedge Fund 0.8998 214398 -19300 2023-06-30 HIGH
    Two Sigma Investments, LP Hedge Fund 0.4789 114093 -6920 2023-06-30 HIGH
    Rhumbline Advisers Ltd. Partnership Investment Advisor 0.0837 19940 19940 2023-06-30 LOW
    HRT Financial LP Investment Advisor 0.0423 10073 10073 2023-06-30 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.0141 3370 0 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Akso Health Group Company profile

    About Akso Health Group - ADR

    Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.

    Financial summary

    BRIEF: For the six months ended 30 September 2021, AksoHealth Group - ADR revenues decreased 82% to $246K. Netloss before extraordinary items decreased 49% to $8.9M.Revenues reflect Interest income decrease of 82% to $187K,Commission services decrease of 81% to $60K. Lower net lossreflects Provision for uncollectable loans receiv decreaseof 61% to $5M (expense), General and administrativedecrease of 25% to $2.3M (expense).

    Industry: E-commerce & Auction Services

    Room 515, Floor 5, Jia No. 92-4 To 24
    Jianguo Road Chaoyang Dist
    BEIJING
    BEIJING 100020
    CN

    Income Statement

    • Annual
    • Quarterly

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    ETH/USD

    1,579.80 Price
    -0.800% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Oil - Crude

    90.00 Price
    -0.120% 1D Chg, %
    Long position overnight fee 0.0414%
    Short position overnight fee -0.0633%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    XRP/USD

    0.50 Price
    -2.310% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    US100

    14,691.10 Price
    -0.200% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading